Cargando…

Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition

Alzheimer’s disease (AD) is defined by the presence of amyloid-β (Aβ) and tau protein aggregates. However, increasing data is suggesting that brain network alterations rather than protein deposition could account for the early pathogenesis of the disease. In the present study, we performed in vitro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mondragón-Rodríguez, Siddhartha, Gu, Ning, Manseau, Frederic, Williams, Sylvain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952042/
https://www.ncbi.nlm.nih.gov/pubmed/29867356
http://dx.doi.org/10.3389/fncel.2018.00121
_version_ 1783323118361640960
author Mondragón-Rodríguez, Siddhartha
Gu, Ning
Manseau, Frederic
Williams, Sylvain
author_facet Mondragón-Rodríguez, Siddhartha
Gu, Ning
Manseau, Frederic
Williams, Sylvain
author_sort Mondragón-Rodríguez, Siddhartha
collection PubMed
description Alzheimer’s disease (AD) is defined by the presence of amyloid-β (Aβ) and tau protein aggregates. However, increasing data is suggesting that brain network alterations rather than protein deposition could account for the early pathogenesis of the disease. In the present study, we performed in vitro extracellular field recordings in the CA1/subiculum area of the hippocampus from 30 days old J20-TG-AD mice. Here, we found that theta oscillations were significantly less rhythmic than those recorded from control group. In addition, J20 mice displayed significantly less theta-gamma cross-frequency coupling (CFC) as peak modulation indexes for slow (25–45 Hz) and fast (150–250 Hz) gamma frequency oscillations were reduced. Because inhibitory parvalbumin (PV) cells play a vital role in coordinating hippocampal theta and gamma oscillations, whole-cell patch-clamp recordings and extracellular stimulation were performed to access their intrinsic and synaptic properties. Whereas neither the inhibitory output of local interneurons to pyramidal cells (PCs) (inhibitory→PC) nor the excitatory output of PCs to PV cells (PC→PV) differed between control and J20 animals, the intrinsic excitability of PV cells was reduced in J20 mice compared to controls. Interestingly, optogenetic activation of PV interneurons which can directly drive theta oscillations in the hippocampus, did not rescue CFC impairments, suggesting the latter did not simply result from alteration of the underlying theta rhythm. Altered young J20 mice was characterized by the presence of β-CTF, but not with Aβ accumulation, in the hippocampus. Importantly, the β secretase inhibitor AZD3839-AstraZeneca significantly rescued the abnormal early electrophysiological phenotype of J20 mice. In conclusion, our data show that brain network alterations precede the canonical Aβ protein deposition and that, such alterations can be related to β-CTF fragment.
format Online
Article
Text
id pubmed-5952042
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-59520422018-06-04 Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition Mondragón-Rodríguez, Siddhartha Gu, Ning Manseau, Frederic Williams, Sylvain Front Cell Neurosci Neuroscience Alzheimer’s disease (AD) is defined by the presence of amyloid-β (Aβ) and tau protein aggregates. However, increasing data is suggesting that brain network alterations rather than protein deposition could account for the early pathogenesis of the disease. In the present study, we performed in vitro extracellular field recordings in the CA1/subiculum area of the hippocampus from 30 days old J20-TG-AD mice. Here, we found that theta oscillations were significantly less rhythmic than those recorded from control group. In addition, J20 mice displayed significantly less theta-gamma cross-frequency coupling (CFC) as peak modulation indexes for slow (25–45 Hz) and fast (150–250 Hz) gamma frequency oscillations were reduced. Because inhibitory parvalbumin (PV) cells play a vital role in coordinating hippocampal theta and gamma oscillations, whole-cell patch-clamp recordings and extracellular stimulation were performed to access their intrinsic and synaptic properties. Whereas neither the inhibitory output of local interneurons to pyramidal cells (PCs) (inhibitory→PC) nor the excitatory output of PCs to PV cells (PC→PV) differed between control and J20 animals, the intrinsic excitability of PV cells was reduced in J20 mice compared to controls. Interestingly, optogenetic activation of PV interneurons which can directly drive theta oscillations in the hippocampus, did not rescue CFC impairments, suggesting the latter did not simply result from alteration of the underlying theta rhythm. Altered young J20 mice was characterized by the presence of β-CTF, but not with Aβ accumulation, in the hippocampus. Importantly, the β secretase inhibitor AZD3839-AstraZeneca significantly rescued the abnormal early electrophysiological phenotype of J20 mice. In conclusion, our data show that brain network alterations precede the canonical Aβ protein deposition and that, such alterations can be related to β-CTF fragment. Frontiers Media S.A. 2018-05-08 /pmc/articles/PMC5952042/ /pubmed/29867356 http://dx.doi.org/10.3389/fncel.2018.00121 Text en Copyright © 2018 Mondragón-Rodríguez, Gu, Manseau and Williams. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Mondragón-Rodríguez, Siddhartha
Gu, Ning
Manseau, Frederic
Williams, Sylvain
Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
title Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
title_full Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
title_fullStr Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
title_full_unstemmed Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
title_short Alzheimer’s Transgenic Model Is Characterized by Very Early Brain Network Alterations and β-CTF Fragment Accumulation: Reversal by β-Secretase Inhibition
title_sort alzheimer’s transgenic model is characterized by very early brain network alterations and β-ctf fragment accumulation: reversal by β-secretase inhibition
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952042/
https://www.ncbi.nlm.nih.gov/pubmed/29867356
http://dx.doi.org/10.3389/fncel.2018.00121
work_keys_str_mv AT mondragonrodriguezsiddhartha alzheimerstransgenicmodelischaracterizedbyveryearlybrainnetworkalterationsandbctffragmentaccumulationreversalbybsecretaseinhibition
AT guning alzheimerstransgenicmodelischaracterizedbyveryearlybrainnetworkalterationsandbctffragmentaccumulationreversalbybsecretaseinhibition
AT manseaufrederic alzheimerstransgenicmodelischaracterizedbyveryearlybrainnetworkalterationsandbctffragmentaccumulationreversalbybsecretaseinhibition
AT williamssylvain alzheimerstransgenicmodelischaracterizedbyveryearlybrainnetworkalterationsandbctffragmentaccumulationreversalbybsecretaseinhibition